Skip to content

H.R. 661 · 119th Congress (2025–2027)

MIRACLE Medical Technology Act of 2025

This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.

Show official title

To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 661’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Vern Buchanan (R-FL-16)
Cosponsors
3 cosponsors

2 original · 1 later

  1. Rep. Mariannette Miller-Meeks (R-IA-1)· Original · Jan 23, 2025
  2. Rep. Darren Soto (D-FL-9)· Original · Jan 23, 2025
  3. Rep. Thomas R. Suozzi (D-NY-3)· Later · Dec 23, 2025
Policy area
Health
Subjects
  • Advanced technology and technological innovations
  • Advisory bodies
  • Data collection, sharing, protection
  • Diplomacy, foreign officials, Americans abroad
  • Employment and training programs
  • Health promotion and preventive care
  • Health technology, devices, supplies
  • Intellectual property
  • 6 more
    • Israel
    • Manufacturing
    • Medical research
    • Prescription drugs
    • Public-private cooperation
    • Supply chain

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Jan 23, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. MIRACLE Medical Technology Act of 2025

    Display title, Short title · Introduced in House

  2. Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025

    Short title · Introduced in House

  3. To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare & Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.

    Official title · Introduced in House